Zivo Bioscience Free Cash Flow (FCF) History (ZIVO)

Zivo Bioscience reported −$3.0M in free cash flow for fiscal 2013, a decrease of $1.2M from the previous fiscal year.

View full Zivo Bioscience company overview

Zivo Bioscience free cash flow by year

Zivo Bioscience annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20132013-12-31−$3.0M−$1.2M
20122012-12-31−$1.8M−$477,916
20112011-12-31−$1.3M$170,508−1250.20%
20102010-12-31−$1.5M−1776.19%

Zivo Bioscience free cash flow growth trends

Zivo Bioscience's latest reported quarter, Q3 2013, generated −$783,470 in free cash flow, a decrease of $249,261 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Zivo Bioscience filings at SEC.gov ↗